Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 53844-02-3 | MDL No. : | MFCD09909490 |
Formula : | C10H12BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HREXFDIZSAUXBO-UHFFFAOYSA-N |
M.W : | 258.11 | Pubchem ID : | 278694 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 58.17 |
TPSA : | 38.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.14 cm/s |
Log Po/w (iLOGP) : | 2.56 |
Log Po/w (XLOGP3) : | 2.44 |
Log Po/w (WLOGP) : | 2.16 |
Log Po/w (MLOGP) : | 2.24 |
Log Po/w (SILICOS-IT) : | 2.17 |
Consensus Log Po/w : | 2.31 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.9 |
Solubility : | 0.326 mg/ml ; 0.00126 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.89 |
Solubility : | 0.334 mg/ml ; 0.00129 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.21 |
Solubility : | 0.016 mg/ml ; 0.0000619 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 13.33 h; Inert atmosphere | A cooled (0° C.) mixture of 2-bromoethylamine hydrobromide (12.000 g ; 58.56 mmol ; 1.0 eq.) in dioxane (60 ml) was treated with aq. 1M NaOH (117.2 ml ; 117.20 mmol ; 2.0 eq.), and dropwise (over 10 min.) with benzyl chloroformate (8.4 ml ; 58.8 mmol ; 1.0 eq.). The resulting mixture was further stirred at 0° C., under nitrogen, for 10 min., and then at rt for 13 h. Et2O (300 ml) was added, and the colorless organic layer was further washed with water (75 ml), dried over anh. MgSO4, filtered, and finally concentrated to dryness under reduced pressure to afford (2-bromo-ethyl)-carbamic acid benzyl ester as a colorless oil which was further dried under HV (15.020 g ; 99percent). LC-MS: tR=0.95 min. ; [M+H]+: no ionisation. |
99% | With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 13.3333 h; Inert atmosphere | B.3 /V-alkylation of imidazoles with Br(CH2^NHBoC or with (2-bromo-ethyl)-carbamic acid benzyl ester; Preparation of (2-bromo-ethyl)-carbamic acid benzyl ester; A cooled (00C) mixture of 2-bromoethylamine hydrobromide (12.000 g; 58.56 mmol; 1.0 eq.) in dioxane (60 ml) was treated with aq. 1 M NaOH (117.2 ml; 117.20 mmol; 2.0 eq.), <n="50"/>and dropwise (over 10 min.) with benzyl chloroformate (8.4 ml; 58.8 mmol; 1.0 eq.). The resulting mixture was further stirred at 00C, under nitrogen, for 10 min., and then at rt for 13h. Et2O (300 ml) was added, and the colorless organic layer was further washed with water (75 ml), dried over anh. MgSO4, filtered, and finally concentrated to dryness under reduced pressure to afford (2-bromo-ethyl)-carbamic acid benzyl ester as a colorless oil which was further dried under HV (15.020 g; 99percent). LC-MS: tR = 0.95 min.; [M+H]+: no ionisation. |
95% | With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; | Treat a 0 °C solution of 2-bromoethylamine hydrobromide (50 g, 0.246 mol) in dioxane (500 mL) with aqueous NaOH (1 M, 492 mL, 0.492 mol), add benzyl chloroformate (21.6 g, 0.127 mol) drop-wise, warm to RT and stir overnight. Pour the mixture into H20, extract with EtOAc (3X), wash the combined organics with brine, dry over Na2S04, concentrate to dryness and purify via silica gel chromatography (EtOAc/Petroleum ether) to afford the title compound (60 g, 95percent) as a white solid. 1H NMR (400 MHz, CDC13): δ 7.37-7.33 (m, 5 H), 5.12 (s, 2 H), 3.61 (t, J = 5.6 Hz, 2 H), 3.47 (t, J= 5.6 Hz, 2 H). |
87% | With triethylamine In ethanol at 20℃; for 20 h; | General Synthesis Instructions for N-Z-2-bromoethylamine/N-Z-3-bromopropylamine: Add a solution of 1.5 equivalents of benzylchloroformiate in 50 ml Rotisol in drops to a solution of one equivalent of 2-bromoethylamine-hydrobromide or 3-bromopropylamine-hydrobromide and three equivalents of triethylamine in 150 ml Rotisol under refrigeration. Stir for 20 hours at room temperature, then concentrate the formulation to a small volume, take it up in 200 ml ethyl acetate, and extract twice against 200 ml 2 N hydrochloric acid each time. Remove the solvent and purify the residue via column chromatography on 100 g silica gel. Elute the apolar impurities with cyclohexane/diisopropyl ether (10:1), and elute the product with diisopropyl ether; N-Z-2-bromoethylamine (72): Quantities Used: 34.8 g (170 mmol) 2-bromoethylamine-hydrobromide, 72.0 ml (255 mmol) 50percent solution of benzylchloroformiate in toluene, 70.6 ml (510 mmol) triethylamine |
64% | With N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 2 h; | To a solution of 2-bromoethylamine bromide (5 g, 24.4 mmole) in DMF (50 mL) was added diisopropylethylamine (8.5 mL, 48.8 mmole) and benzyl chloroformate (3.48 mL, 24.4 mmole). The mixture thus obtained was stirred at room temperature for 2 hours. The reaction mixture was concentrated and the residue was purified by flash chromatography on silica gel with ethyl acetate/hexanes (3/7) as eluent to give the desired compound 34 as an oil (4 g, 64percent). 1H NMR (CDCl3) No. 3.54 (bs, 2H), 3.61 (bs, 2H), 5.12 (s, 2H), 7.36 (m, 5H). |
64% | With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 2 h; | Synthesis of Compound 1: To a solution of 2-bromoethylamine bromide (5 g, 24.4 mmole) in DMF (50 mL) was added diisopropylethylamine (8.5 mL, 48.8 mmole) and benzyl chlroroformate (3.48 mL, 24.4 mmole). The mixture thus obtained was stirred at room temperature for 2 hours. The reaction mixture was concentrated and the residue was purified by flash chromatography on silica gel with ethyl acetate/hexanes (3/7) as gradient to give Compound 1 as an oil (4 g, 64percent). 1H NMR (CDCl3) δ 3.54 (bs, 2H), 3.61 (bs, 2H), 5.12 (s, 2H), 7.36 (m, 5H). |
[ 39945-54-5 ]
Benzyl (3-bromopropyl)carbamate
Similarity: 0.89
[ 72080-83-2 ]
Benzyl (2-aminoethyl)carbamate
Similarity: 0.87
[ 18807-71-1 ]
Benzyl N-(2-aminoethyl)carbamate hydrochloride
Similarity: 0.85
[ 46460-73-5 ]
Benzyl (3-aminopropyl)carbamate
Similarity: 0.85
[ 277328-34-4 ]
1-Cbz-Amino-2-methylaminoethane hydrochloride
Similarity: 0.85
[ 39945-54-5 ]
Benzyl (3-bromopropyl)carbamate
Similarity: 0.89
[ 340187-12-4 ]
(9H-Fluoren-9-yl)methyl (2-bromoethyl)carbamate
Similarity: 0.82
[ 186663-83-2 ]
(9H-Fluoren-9-yl)methyl (3-bromopropyl)carbamate
Similarity: 0.75
[ 159275-17-9 ]
Benzyl 4-(Bromomethyl)tetrahydro-1(2H)-pyridinecarboxylate
Similarity: 0.75
[ 799767-82-1 ]
Benzyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate
Similarity: 0.69
[ 39945-54-5 ]
Benzyl (3-bromopropyl)carbamate
Similarity: 0.89
[ 72080-83-2 ]
Benzyl (2-aminoethyl)carbamate
Similarity: 0.87
[ 18807-71-1 ]
Benzyl N-(2-aminoethyl)carbamate hydrochloride
Similarity: 0.85
[ 46460-73-5 ]
Benzyl (3-aminopropyl)carbamate
Similarity: 0.85
[ 277328-34-4 ]
1-Cbz-Amino-2-methylaminoethane hydrochloride
Similarity: 0.85
[ 39945-54-5 ]
Benzyl (3-bromopropyl)carbamate
Similarity: 0.89
[ 72080-83-2 ]
Benzyl (2-aminoethyl)carbamate
Similarity: 0.87
[ 18807-71-1 ]
Benzyl N-(2-aminoethyl)carbamate hydrochloride
Similarity: 0.85
[ 46460-73-5 ]
Benzyl (3-aminopropyl)carbamate
Similarity: 0.85
[ 277328-34-4 ]
1-Cbz-Amino-2-methylaminoethane hydrochloride
Similarity: 0.85